Zdrowie i gospodarka · 21/12/2023
FDA Announces Final Guidance for Monoclonal Antibody Products Targeting SARS-CoV-2
The FDA has released a final guidance for the development of monoclonal antibody products targeting SARS-CoV-2 for emergency use authorization, addressing emerging variants and COVID-19 prevention or treatment.
Source: Federal Register — Food and Drug AdministrationOpen original release →